D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$751M |
| 2 |
Advanced Micro Devices
AMD
|
+$751M |
| 3 |
Micron Technology
MU
|
+$426M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$363M |
| 5 |
ExxonMobil
XOM
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$546M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$485M |
| 3 |
VMW
VMware, Inc
VMW
|
+$393M |
| 4 |
Microsoft
MSFT
|
+$336M |
| 5 |
UnitedHealth
UNH
|
+$303M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.03% |
| 2 | Consumer Discretionary | 9.51% |
| 3 | Healthcare | 5.76% |
| 4 | Financials | 5.47% |
| 5 | Communication Services | 4.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BBBY
1676
PUT
Bed Bath & Beyond
BBBY
$512M
| $5.65M | ﹤0.01% |
224,400
+31,240
| +16% | +$538K |
|
1677
Bumble
BMBL
$386M
| $5.64M | ﹤0.01% |
382,946
+333,550
| +675% | +$4.73M |
|
1678
Frontline
FRO
$8.59B
| $5.64M | ﹤0.01% |
281,481
-1,209,478
| -81% | -$25M |
|
|
TBCH
1679
Turtle Beach Corp
TBCH
$245M
| $5.64M | ﹤0.01% |
514,991
+4,713
| +0.9% | +$46.2K |
|
1680
Sprinklr
CXM
$1.42B
| $5.64M | ﹤0.01% |
468,158
-382,926
| -45% | -$5.26M |
|
|
ALPN
1681
DELISTED
Alpine Immune Sciences Inc
ALPN
| $5.63M | ﹤0.01% |
295,542
+246,911
| +508% | +$3.43M |
|
1682
Hain Celestial
HAIN
$46M
| $5.61M | ﹤0.01% |
512,326
-177,777
| -26% | -$1.92M |
|
|
FL
1683
CALL
DELISTED
Foot Locker
FL
| $5.61M | ﹤0.01% |
180,000
+74,100
| +70% | +$1.79M |
|
1684
Dominion Energy
D
$61.8B
| $5.59M | ﹤0.01% |
119,012
-211,600
| -64% | -$9.45M |
|
1685
State Street SPDR S&P Bank ETF
KBE
$1.63B
| $5.59M | ﹤0.01% |
+121,469
| New | +$4.81M |
|
1686
GE HealthCare
GEHC
$27.8B
| $5.58M | ﹤0.01% |
72,147
+22,298
| +45% | +$1.56M |
|
1687
Weibo
WB
$1.92B
| $5.57M | ﹤0.01% |
508,682
+49,045
| +11% | +$557K |
|
1688
Vestis
VSTS
$2.03B
| $5.57M | ﹤0.01% |
+263,347
| New | +$4.52M |
|
|
DOOR
1689
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $5.57M | ﹤0.01% |
65,740
+22,942
| +54% | +$1.99M |
|
|
SMLR
1690
DELISTED
Semler Scientific
SMLR
| $5.56M | ﹤0.01% |
125,587
+13,774
| +12% | +$495K |
|
1691
Scholastic
SCHL
$769M
| $5.55M | ﹤0.01% |
147,176
+25,447
| +21% | +$973K |
|
1692
Pultegroup
PHM
$24.9B
| $5.54M | ﹤0.01% |
53,690
-79,796
| -60% | -$6.78M |
|
1693
Novartis
NVS
$297B
| $5.53M | ﹤0.01% |
54,817
-70,106
| -56% | -$6.77M |
|
1694
Zumiez
ZUMZ
$328M
| $5.53M | ﹤0.01% |
272,043
+32,209
| +13% | +$577K |
|
1695
Equinox Gold
EQX
$7.51B
| $5.52M | ﹤0.01% |
1,130,814
+412,073
| +57% | +$1.95M |
|
|
SAGE
1696
DELISTED
Sage Therapeutics
SAGE
| $5.52M | ﹤0.01% |
254,667
+52,465
| +26% | +$1.04M |
|
1697
CALL
AB InBev
BUD
$156B
| $5.52M | ﹤0.01% |
85,400
-19,500
| -19% | -$1.15M |
|
1698
Otis Worldwide
OTIS
$27.9B
| $5.51M | ﹤0.01% |
61,562
-242,599
| -80% | -$20.2M |
|
|
ERF
1699
DELISTED
Enerplus Corporation
ERF
| $5.51M | ﹤0.01% |
359,384
+119,000
| +50% | +$1.93M |
|
1700
AdvanSix
ASIX
$546M
| $5.5M | ﹤0.01% |
183,576
+32,856
| +22% | +$913K |
|
Similar funds
D.E. Shaw & Co's Q4 2023 Portfolio in Review
As of Q4 2023, D.E. Shaw & Co held 4,806 positions worth $114B, up 19% from $95.8B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
D.E. Shaw & Co's Q4 2023 filing shows 575 new, 1,549 increased, 1,464 reduced and 527 closed positions. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $546M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- D.E. Shaw & Co's largest Q4 2023 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M.
- D.E. Shaw & Co added most to Netflix in Q4 2023, an estimated $751M increase.
- D.E. Shaw & Co's biggest Q4 2023 reduction was Microsoft, cutting an estimated $336M.
- D.E. Shaw & Co fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $546M.
- D.E. Shaw & Co's ten largest holdings make up 12% of its $114B portfolio in Q4 2023.
- D.E. Shaw & Co opened 575 new positions and closed 527 in Q4 2023.
- D.E. Shaw & Co's portfolio value rose 19% quarter-over-quarter to $114B.
Based on D.E. Shaw & Co's 13F filing for Q4 2023, filed 14 Feb 2024.